Nav: Home

New avenue for anti-depressant therapy discovered

January 24, 2017

Finnish researchers have made a ground-breaking discovery revealing new molecular information on how the brain regulates depression and anxiety. They found that a protein called JNK when active, represses the generation of new neurons in the hippocampus. By inhibiting JNK solely in newly generated nerve cells in this region, they were able to alleviate anxiety and depressive behaviour in mice.

The work was led by research director Eleanor Coffey, who works at the Turku Centre for Biotechnology, a joint unit of the University of Turku and Åbo Akademi University.

We identified a new molecule that alleviates anxiety and depressive behaviour in rodents. This previously unknown mechanism brings fresh insight on how the brain works to regulate mood and indicates that inhibitors of JNK, such as the one used here, can provide a new avenue for anti-depressant and anxiolytic drug development, Coffey says.

Depression and anxiety are highly prevalent disorders and represent one of the largest causes of disability worldwide. These results are important as many patients to not respond to current treatments and it has long been recognised that new mechanistic understanding of these disorders would be necessary in order to identify drugs for treatment resistant depression.

Researchers used virus tools to find out where in the brain the JNK inhibitor acted to improve mood. They found out the molecule acts to alleviate anxiety and depression by controlling newly born nerve cells in the hippocampus, a part of the brain that controls emotions and learning.

The next step will be to do further tests in rodents. Researchers will test JNK:s additional benefit to existing anti-depressant drugs.

Although we uncover a new mechanism and a new inhibitor molecule that alleviates depression and anxiety in mice, we need to see if this provides additional benefit to existing drugs. Thus, we will do experiments where we administer this new inhibitor together with commonly used drugs and measure fine behavioral details in the mice, Coffey says.

The inhibitor that researchers used is already in clinical trials for stroke and hearing loss.

Actually many large pharma have over the years developed a range of inhibitors to JNK. However it was not earlier known that JNK regulated emotional behavior, so an important message from this study is that JNK should be considered seriously as a target for novel treatments of anxiety and depression.
-end-
The work, led by Eleanor Coffey, Research Director at Åbo Akademi University is a collaborative effort between scientists in Finland and the US. The research was funded by the EU-funded Marie Curie Initial Training Network r'BIRTH, by the Academy of Finland, Turku Network in Molecular Biosciences and the National Institute on Aging.

The results are published in the Nature Publishing Group Journal, Molecular Psychiatry. Link to publication: http://www.nature.com/mp/journal/vaop/ncurrent/full/mp2016203a.html

PHOTO https://apps.utu.fi/media/tiedostot/dcx.png: The image, taken at the Cell Imaging Core, shows these new born cells in the hippocampus, the region of the brain that controls emotions.

More information: research director Eleanor Coffey, eleanor.coffey@btk.fi

University of Turku

Related Depression Articles:

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.
Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.
CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.
Post-natal depression in dads linked to depression in their teenage daughters
Fathers as well as mothers can experience post-natal depression -- and it is linked to emotional problems for their teenage daughters, new research has found.
Being overweight likely to cause depression, even without health complications
A largescale genomic analysis has found the strongest evidence yet that being overweight causes depression, even in the absence of other health problems.
More Depression News and Depression Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...